Clinical trial
Prospective Cohort Study of Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients
NCT07324291 is registered in ClinicalTrials.gov with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study of Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Lead sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2026
- Completion date
- June 30, 2027
- Enrollment
- 1,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
allogeneic hematopoietic stem cell transplantation, carbapenem-resistant enterobacterales